Provider review
Somira Health review
Publishes the quarterly charge, its per-month division and a monthly rate together.
The size of the commitment discount is legible on the page instead of implied.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Somira Health
$189.99/mo month-to-month; a quarterly prepay divides to less
- Vs median
- $20/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A referenced
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Most sellers with a commitment ladder publish the monthly division and stop there, which is how a reader ends up surprised by the size of the charge that actually lands. Somira publishes the charge, the division and the monthly alternative for both molecules, side by side, so the trade is completely legible before you sign anything. The gap between the two rungs is where the real information sits: the month-to-month rate runs roughly a quarter to two fifths above the quarterly division, which tells you exactly what committing buys and lets you decline it knowingly. Two smaller things are handled well. Cancellation and pausing are both offered rather than only cancellation, and pausing is the more useful of the two when you are adjusting a dose or waiting out a side effect. And a footnote puts alcohol wipes and syringes inside the price, which closes the commonest small gap in this category, where supplies turn up as a separate line after the first order. No milligram appears against any of the four figures.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see the amount charged, not just the monthly division of it
- You want the option to pause rather than only to cancel
- You want supplies inside the price rather than added later
Look elsewhere if
- You want the lowest figure without committing — the monthly rate is well above the quarterly one
- You want a low-dose product; none is offered
- You want a dose behind the number
What it actually costs
Price as published
★★★ ALL THREE NUMBERS ARE ON THE PAGE FOR BOTH MOLECULES. Semaglutide: "Quarterly Plan: $136.66/month — $409.99/quarter" beside "Monthly Plan: $189.99/monthly". Tirzepatide: "Quarterly Plan: $193.33/month — $579.99/quarter" beside "Monthly Plan: $239.99/monthly" · so a reader sees the amount actually charged, the division that produces the advertised figure, and the no-commitment rate, without doing any arithmetic or reaching a checkout · ★ the monthly rungs are roughly 39% and 24% above the quarterly divisions, which is the real size of the commitment discount and it is legible here rather than inferred · "Cancel or pause at any time" is stated, and a footnote adds that prices "include alcohol wipes and syringes", so the supplies are inside the figure · the 503A class is referenced once · no milligram is published
- Vs median
- $20/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★★★ No low-dose product, but the commitment ladder is published the way one should be: the amount charged, the division it produces and the no-commitment monthly rate, all three, for both molecules. The size of what committing buys is therefore legible rather than implied, and a reader can decline it knowingly. ★ Pausing is offered alongside canceling, which matters more to anyone adjusting a dose. No dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Publishes the quarterly charge, its per-month division and a monthly rate, all three, for both molecules.
- States pausing as well as canceling, which matters more when a dose is being adjusted.
- Puts alcohol wipes and syringes inside the price rather than adding them later.
Pharmacy, labs and oversight
Somira Health dispenses through a 503A referenced facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Somira Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Most sellers with a commitment ladder publish the division and stop there, which is how a reader ends up surprised by the size of the charge. Somira publishes the charge, the division and the monthly alternative for both molecules, side by side, which makes the trade completely legible before anyone signs anything. The gap between the two rungs is where the information is: the month-to-month rate runs roughly a quarter to two fifths above the quarterly division, so what committing actually buys is visible instead of implied. Two smaller things are handled well. Cancellation and pausing are both stated rather than only cancellation, which is the more useful pair for anyone titrating. And the footnote putting alcohol wipes and syringes inside the price closes the commonest small gap in this category, where supplies turn up as a separate line later. No milligram appears against any of the four figures.
The honest cons
The month-to-month rate runs roughly a quarter to two fifths above the quarterly division.
- No milligram is published against any of the four figures.
- Only one pharmacy class reference appears on the whole site.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Somira Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#329 of 373
Ordered with the companies that pay us first, and Somira Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.